tiprankstipranks
Trending News
More News >
Prothena (PRTA)
NASDAQ:PRTA

Compare Prothena (PRTA) vs. Competitors

Compare
672 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Prothena
$10.00
$538.30M
-1.92
-35.40%
4 Buy
1 Hold
1 Sell
Moderate Buy
Lexicon Pharmaceuticals
$1.70
$617.78M
-8.97
92.09%
3 Buy
0 Hold
0 Sell
Strong Buy
Xoma
$26.70
$330.63M
35.81
2.65%
4 Buy
1 Hold
0 Sell
Strong Buy
Zevra Therapeutics
$8.97
$504.99M
14.22
10.74%
6 Buy
0 Hold
0 Sell
Strong Buy
Corvus Pharmaceuticals
$25.10
$1.87B
-46.92
373.58%
5 Buy
0 Hold
0 Sell
Strong Buy
Alumis Inc.
$26.68
$3.06B
-6.36
273.21%
7 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PRTA
Prothena
10.00
-6.04
-37.66%
LXRX
Lexicon Pharmaceuticals
1.70
0.74
77.08%
XOMA
Xoma
26.70
-0.56
-2.05%
ZVRA
Zevra Therapeutics
8.97
0.87
10.74%
CRVS
Corvus Pharmaceuticals
25.10
20.03
395.07%
ALMS
Alumis Inc.
24.52
17.77
263.26%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts